Your kidneys filter roughly 50 gallons of blood every day, quietly removing waste and keeping your internal chemistry in balance. Creatinine (a breakdown product of creatine phosphate, the energy reserve in your muscles) is one of the substances your kidneys are supposed to clear. When filtering slows down, creatinine accumulates in your blood. That makes your creatinine level one of the simplest, most widely available signals of kidney health you can track.
The catch is that creatinine can stay in the "normal" range even after you have lost more than half your kidney filtering capacity. By the time the number on your lab report looks obviously abnormal, significant kidney function may already be gone. That is why understanding what your number means, how to read it in context, and why tracking your personal trend matters far more than any single reading.
Your muscles produce creatinine at a nearly constant rate every day, roughly 2% of your total creatine supply converts to creatinine through a spontaneous chemical reaction. Because production is so steady, changes in your blood creatinine level almost always reflect changes in how fast your kidneys are clearing it. Doctors use your creatinine value (along with your age and sex) to calculate an estimated glomerular filtration rate, or eGFR, which is the standard measure of kidney filtering power.
A higher creatinine means slower kidney clearance. A lower creatinine usually means your kidneys are clearing efficiently, though it can also mean you have less muscle mass producing creatinine in the first place. This distinction matters, especially as you age.
Kidney function and heart health are tightly linked. Even mild reductions in kidney filtering that do not produce symptoms are associated with meaningfully higher cardiovascular risk. A study of more than 648,000 people found that for every 5 mL/min/1.73 m² drop in eGFR below 60, the risk of coronary heart disease rose by about 14%. Genetic analysis in the same study confirmed this was not just correlation: lower kidney function appears to directly contribute to heart disease risk.
In a Japanese cohort of over 91,000 adults followed for 10 years, men with the highest creatinine levels (1.3 mg/dL or above) had about 1.5 times the risk of dying from cardiovascular disease compared to those with the lowest levels. For women, the gap was even wider: those with levels at or above 1.1 mg/dL faced roughly double the cardiovascular death risk.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 648,135 adults across four large cohorts | Coronary heart disease risk per 5 mL/min drop in eGFR (below 60) | About 14% higher risk per 5-unit drop, confirmed by genetic analysis |
| 91,432 Japanese adults followed 10 years | Highest vs. lowest creatinine groups | Men: roughly 1.5x higher cardiovascular death risk; Women: roughly 2x higher risk |
| 10,489 Danish adults followed 32 years | Top 5% of creatinine vs. below the 75th percentile | About 1.4x higher risk of heart attack and 1.7x higher risk of death |
What this means for you: even a creatinine value near the upper end of "normal" for your age and sex may signal cardiovascular risk worth investigating further, especially if it is trending upward.
Elevated creatinine is independently tied to stroke risk after accounting for blood pressure and other standard risk factors. In a study of nearly 7,700 middle-aged British men followed for almost 15 years, those with creatinine above 1.31 mg/dL (the 90th percentile) had about 1.6 times the risk of stroke compared to the rest of the group. Among older adults over 70, the association was even stronger: an eGFR between 45 and 59 was linked to roughly 2.2 times higher stroke risk over about 8 years of follow-up.
The link between creatinine (via eGFR) and kidney outcomes is the most direct and well-studied. A massive analysis pooling data from over 27.5 million people across 114 cohorts found a steep, graded relationship: as eGFR drops, the risk of kidney failure, death, and hospitalization all climb. At an eGFR of 45 to 59 (mildly to moderately reduced), hospitalization risk was already about 1.3 times higher than at normal levels. At an eGFR below 15, the risk of death tripled.
The rate of change matters, too. A separate analysis of 1.7 million people showed that a decline of more than 30% in eGFR over just two years dramatically increased the likelihood of progressing to kidney failure and death, even among people whose starting kidney function was only mildly reduced.
A meta-analysis of over 1.1 million people showed that mortality risk rises in a clear stepwise pattern as eGFR falls. Compared to an eGFR of 95 (a healthy reference), an eGFR of 60 carried about 1.2 times higher death risk. At an eGFR of 45, that climbed to roughly 1.6 times. At an eGFR of 15, mortality risk was about 3 times higher. These associations held after adjusting for blood pressure, diabetes, and other standard risk factors.
Even small creatinine increases carry weight. In one study, each 5 micromol/L increase in serum creatinine was associated with about 11% higher cardiovascular death risk, independent of blood pressure, cholesterol, and inflammation markers.
Your creatinine number means little in isolation. It must be interpreted in context of your muscle mass, age, sex, and diet. The same value that is normal for a muscular 30-year-old man could signal significant kidney impairment in a small-framed elderly woman.
| Group | Typical Range (mg/dL) | Context |
|---|---|---|
| Adult women (ages 20 to 70) | 0.50 to 0.90 | Lower muscle mass produces less creatinine |
| Adult men (ages 20 to 70) | 0.70 to 1.20 | Higher muscle mass raises baseline production |
| Adults over 70 | May rise slightly above these ranges | Reflects normal age-related decline in kidney filtering, even as muscle mass decreases |
These ranges are based on standardized enzymatic assay methods traceable to international reference materials. Your lab may report slightly different values depending on the method used. The most meaningful comparison is always your own result over time within the same lab.
What matters more than the raw creatinine number is the eGFR your lab calculates from it. The current standard uses the CKD-EPI 2021 equation, which factors in your age and sex. Here is how eGFR stages map to kidney function.
| eGFR (mL/min/1.73 m²) | Stage | What It Means |
|---|---|---|
| 90 or above | G1: Normal or high | Kidneys are filtering well; the lowest mortality risk falls in the 90 to 104 range |
| 60 to 89 | G2: Mildly decreased | Slight reduction, often without symptoms; may warrant monitoring |
| 45 to 59 | G3a: Mildly to moderately decreased | Filtering is noticeably reduced; cardiovascular risk begins to climb |
| 30 to 44 | G3b: Moderately to severely decreased | Complications become more likely; closer monitoring and possible medication changes needed |
| 15 to 29 | G4: Severely decreased | Serious impairment; nephrology referral recommended |
| Below 15 | G5: Kidney failure | Kidneys can no longer sustain health independently |
Recent population data suggests that people with eGFR values below the 25th percentile for their age and sex face increased risk of kidney failure and death, even when eGFR is technically above 60. This reinforces the value of knowing where you stand relative to your peers, not just whether you clear an arbitrary threshold.
A single creatinine reading is a snapshot. Your trend over time is the real story. Creatinine has a relatively low biological variability (about 4 to 6% from day to day within the same person), which means genuine changes are usually distinguishable from random noise. A change of roughly 12 to 17% in your eGFR is considered the threshold for a meaningful shift rather than normal fluctuation.
Tracking is especially powerful for three reasons. First, because creatinine can sit in the normal range while kidney function silently erodes, a trajectory heading in the wrong direction can alert you before any single reading crosses a clinical cutpoint. Second, if you are making lifestyle changes (adjusting protein intake, starting or stopping a medication, beginning an exercise program), serial measurements let you see whether those changes are actually affecting your kidney function. Third, a stable creatinine trend over years is itself reassuring in a way that no single lab draw can be.
Get a baseline measurement, then retest in 3 to 6 months if you are making changes that could affect kidney function. After that, at least once a year. If your eGFR is below 60 or trending downward, test every 3 to 6 months until you establish a stable pattern.
Creatinine is one of the most commonly misinterpreted lab values because so many factors besides kidney function can move it. Knowing what can distort your reading helps you avoid unnecessary worry or false reassurance.
Several common medications can also raise creatinine by blocking the kidney's tubular secretion of creatinine, not by harming the kidney itself. Trimethoprim (an antibiotic), cimetidine (a heartburn drug), and fenofibrate (a cholesterol-lowering drug) are common culprits. These can cause creatinine elevations of 10 to 30% that look like kidney injury but are not. If your creatinine rises after starting a new medication, a cystatin C test can help determine whether your kidneys are truly affected or whether the medication is simply interfering with creatinine clearance.
This deserves its own emphasis. Creatinine's biggest weakness as a kidney marker is its dependence on how much muscle you carry. As you age, you naturally lose muscle mass, which pushes creatinine lower. At the same time, your kidneys gradually lose filtering power, which pushes creatinine higher. These two forces can cancel each other out, leaving your creatinine looking stable even as your kidney function declines.
Research shows that in people over 60, creatinine-based eGFR misclassifies kidney function in 15 to 19% of cases. If you have low muscle mass for any reason (age, chronic illness, sedentary lifestyle, low body weight), pairing creatinine with a cystatin C test gives you a much more accurate picture. Cystatin C is produced at a steady rate by nearly all cells in your body, not just muscle, so it is less vulnerable to this particular blind spot.
Evidence-backed interventions that affect your Creatinine level
Creatinine is best interpreted alongside these tests.